My APIC My Courses

Volunteering

APIC Connect/IP Talk APIC Text AJIC Journal Prevention Strategist Staffing Calculator PolicyPro

Join APIC Today Explore Membership

Join

Membership

Membership Benefits and More

Explore the benefits of APIC Membership, including access to resources and communities for infection preventionists.

Become a Member

Join an ever growing community of IPs today.

Join Today

Education

Explore the Education Catalog

Through webinars, Insight Panels, self-study courses, certification preparation, instructor-led intensives, and microcredentials, we empower professionals to strengthen expertise, sharpen critical thinking, and advance their impact.

Long-term Care Outpatient Clinics and Surgery Centers Self-paced Webinars

Research

About the CRPI

The APIC Center for Research, Practice, and Innovation (CRPI) is dedicated to creating a clear and concise pathway from evidence generation for best practices to the dissemination of practice guidance and implementation tools.

Learn More

Initiatives, Publications, and more links

Learn More

Practice Resources

Explore the Resource Library

Your one-stop source for tools intended to complement your practice, including playbooks, guides, toolkits and other resources.

Implementation Guides C. Diff Professional Practice Toolkits

Career Development

Find resources to help you take the next steps in your IP career.

New to Your IP Career?

Check out the Infection Preventionist Onboarding Checklist.

Go to the Checklist

Public Policy

APIC Government Affairs staff works with our Public Policy Committee to ensure that legislators and regulators have the best information to help carry out our mission.

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now

About

About Us

APIC is the nation’s leading association for infection preventionists, advancing science, education, and practice to reduce healthcare-associated infections and improve patient safety.

Learn About our Affiliates

CBIC and APIC Consulting expand the mission of APIC.

Learn More

Back to Policy Updates

FDA Withdraws EUA for Evusheld in US

Post Date: 01/27/2023

Based on data that show Evusheld in unlikely to be effective against SARS-CoV-2 variants currently circulating in the U.S., the FDA announced that Evusheld is not currently authorized for use in the U.S. until further notice. Read the FDA announcement.